Are there npm1 mutation clinical trials in Massachusetts?

Yes. We're currently tracking 4 recruiting npm1 mutation studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a npm1 mutation study in Massachusetts?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Massachusetts to take part?

Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a npm1 mutation trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Massachusetts

NPM1 Mutation clinical trials in Massachusetts

We’re tracking 4 recruiting npm1 mutation studies with a site in Massachusetts — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Massachusetts

NCT06001788RecruitingPhase 1
Ziftomenib for relapsed or refractory acute myeloid leukemia
This trial tests a new drug combination called ziftomenib for people whose acute myeloid leukemia (AML) has come back or hasn't responded to treatment. Researchers will check how safe it is and what side effects happen.
Boston, MassachusettsAges 18 years+
NCT05735184RecruitingPhase 1
Ziftomenib with AML medicines for NPM1- or KMT2A-mutated leukemia
This Phase 1 trial tests how safe and tolerable ziftomenib is when combined with standard AML medicines (like venetoclax and azacitidine, and other chemo options) in people with AML. It’s for AML patients who have specific genetic changes (NPM1 mutation or KMT2A rearrangement) and helps doctors find the best, safest dose plan.
Worcester, MassachusettsAges 18 years+
NCT04065399RecruitingPhase 1/Phase 2
Testing revumenib for relapsed acute leukemia with certain gene changes
This trial tests revumenib, a targeted medicine, to treat acute leukemia that has come back or hasn’t fully gone away. It may help people whose leukemia has specific gene changes (like KMT2A or NPM1) by trying to better control the cancer.
Boston, MassachusettsAges 4 weeks+
NCT06440135RecruitingPhase 1
Ziftomenib maintenance after stem cell transplant for AML
This trial tests if the drug ziftomenib can help prevent AML from coming back after a stem cell transplant. It is for people who have certain gene changes (KMT2A rearrangement or NPM1 mutation) and are in remission or near-remission before transplant.
Boston, MassachusettsAges 18 years+

NPM1 Mutation trials by city in Massachusetts

Boston

Where these studies are running in Massachusetts

Institutions with a site for the recruiting npm1 mutation studies listed above.

Massachusetts General Hospital · 2 studies
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute
University of Massachusetts Chan Medical School

What taking part in a npm1 mutation study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

NPM1 Mutation trials in other states

Ohio

Common questions

Are there npm1 mutation clinical trials in Massachusetts?: Yes. We're currently tracking 4 recruiting npm1 mutation studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a npm1 mutation study in Massachusetts?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Massachusetts to take part?: Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a npm1 mutation trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New npm1 mutation studies open in Massachusetts regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.